For research use only
| Cat No. | ABC-TC0353 |
| Product Type | Human Lung Cancer Cell Lines |
| Cell Type | Lymphoblast |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Blood |
| Disease | Erythroleukemia |
| Product Code | HEL92.1.7; HEL-92.1.7; HEL-92-1-7; HEL-92_1_7; HEL-92; HEL9217 |
HEL-92.1.7 cells undergo erythroblast differentiation and are used for hematopoietic lineage modeling, myeloid response, and TPA induction studies.
HEL-92.1.7 is a human erythroblast cell line derived from the bone marrow of a patient with erythroleukemia. These cells grow in suspension and display erythroid precursor morphology, expressing markers such as glycophorin A and alpha-hemoglobin. This cell line is tumorigenic in immunodeficient mice and forms erythroid tumors with features of differentiation blockage. It is frequently used for studies of erythropoiesis, oncogenic signaling, and drug response in leukemia. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | HEL92.1.7; HEL-92.1.7; HEL-92-1-7; HEL-92_1_7; HEL-92; HEL9217 |
| Species | Human |
| Cat.No | ABC-TC0353 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Lymphoblast |
| Growth Mode | Suspension |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Blood |
| Disease | Erythroleukemia |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Lung Cancer Cell Lines |
HEL-92.1.7 cell line can be used to study erythropoiesis, hematopoietic differentiation, and leukemia biology. It serves as a model for investigating erythroid maturation disorders, translational drug testing, and cancer-specific gene regulation. The cell line also supports drug sensitivity assays and signaling pathway analysis in myeloid malignancies. Its ability to respond to erythropoietin and undergo partial erythroid differentiation further enhances its utility in related research.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
